| 翻訳と辞書 |
| Cofactor Genomics ： ウィキペディア英語版 |
Cofactor Genomics
Cofactor Genomics is a biotech company founded by past Human Genome Project Scientists. Cofactor's mission is to enable drug development, medical research, and personalized medicine using RNA-based information and technologies.
== Overview ==
Cofactor Genomics was founded in August 2008〔() Cofactor Genomics〕 after the pioneering efforts of the Human Genome Project made genetic sequencing a reality by sequencing the 25,000 or so genes in the human genome.〔(Human Genome Project )〕 It was after the technological advances brought on by Next Gen sequencing〔(Next-Gen Sequencing Moves To Next Level )〕 that three scientists from The Genome Center〔() The Genome Genter〕 at Washington University noted that sequencing services could be performed by “three () in a garage.” In August 2008, Jarret Glasscock, Matt Hickenbotham and Ryan Richt left the Genome Center and purchased their first Next Gen genome analyzer with the capital raised from an angel investor in California.〔〔St. Louis Business Journal: St. Louis startup Cofactor to sequence Ozzy's genome ()〕 Cofactor has since been featured in several nationwide publications as well as done business with high profile clients such as Ozzy Osbourne.〔(St. Louis Business Journal )〕〔( GenomeWeb Ozzy )〕〔(GenomeWeb Cofactor / Novocraft )〕〔(A.V. Club )〕〔(STL Today )〕 As of August 2010, Cofactor Genomics is able to construct and analyze fragment, paired end, chip-sequencing, micro RNA, whole transcriptome, bisulfite and capture libraries.〔() Cofactor Genomics Applications〕 Cofactor currently utilizes two Next Gen platforms including an Applied Biosystems SOLiD 4 and an Illumina (company) GA IIx.〔() Cofactor Genomics Platforms〕
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Cofactor Genomics」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|